Portrai Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$9.9M
- Investors
-
13
Portrai General Information
Description
Developer of a spatial transcriptomics platform designed to improve biopsy quality by applying artificial intelligence. The company's platform discovers therapeutic targets and explores potential disease indications with spatial resolution, translates spatial insights into pathophysiology and drug distribution and develops and validates spatial biomarkers and companion diagnostics, enabling healthcare institutions to enhance precision medicine strategies and therapeutic efficacy.
Contact Information
Website
www.portrai.ioCorporate Office
- 7th Floor, 57, Seongsui-ro 22-gil
- Seongdong-gu
- Seoul
- South Korea
Corporate Office
- 7th Floor, 57, Seongsui-ro 22-gil
- Seongdong-gu
- Seoul
- South Korea
Portrai Timeline
Portrai Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Early Stage VC (Series B) | 02-Dec-2025 | $9.9M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | 13-Nov-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Early Stage VC (Series A) | 01-Mar-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 06-Oct-2021 | $679K | $679K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Portrai Patents
Portrai Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026205624-A1 | Antibody or antibody fragment thereof specifically binding to tspan1, and therapeutic, prophylactic, or diagnostic use thereof | Pending | 27-Mar-2025 | ||
| WO-2026205707-A1 | Antxr1-binding antibody and use thereof | Pending | 26-Mar-2025 | ||
| JP-2026513591-A | Method and apparatus for exploring the distribution, efficacy, action, or physiological activity of genome-containing substances within tissues of interest. | Pending | 12-Apr-2023 | ||
| AU-2023442148-A1 | Method and device for exploring distribution, efficacy, action, or physiological activity of genome-containing substances in tissues of interest | Pending | 12-Apr-2023 | ||
| EP-4696771-A1 | Method and device for exploring distribution, efficacy, action, or physiological activity of genome-containing substances in tissues of interest | Pending | 12-Apr-2023 | A61P11/00 |
Portrai Signals
Portrai Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNH Investment | Venture Capital | Minority | ||
| BonAngels Venture Partners | Venture Capital | Minority | ||
| CKD Venture Capital | Corporate Venture Capital | Minority | ||
| Pearl Abyss Capital | Corporate Venture Capital | Minority | ||
| Stic Alternative | Asset Manager | Minority |
Portrai FAQs
-
When was Portrai founded?
Portrai was founded in 2021.
-
Where is Portrai headquartered?
Portrai is headquartered in Seoul, South Korea.
-
What is the size of Portrai?
Portrai has 20 total employees.
-
What industry is Portrai in?
Portrai’s primary industry is Other Healthcare Technology Systems.
-
Is Portrai a private or public company?
Portrai is a Private company.
-
What is Portrai’s current revenue?
The current revenue for Portrai is .
-
How much funding has Portrai raised over time?
Portrai has raised $14.5M.
-
Who are Portrai’s investors?
BNH Investment, BonAngels Venture Partners, CKD Venture Capital, Pearl Abyss Capital, and Stic Alternative are 5 of 13 investors who have invested in Portrai.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process